Maina Bhaman
InvestorPartner at Sofinnova Partners · Board director at Mediar Therapeutics
London
Writes $100K – $5M checks · typically $1.5M
About
Maina Bhaman is a Partner in Sofinnova's Capital Strategy, who joined in 2018 with a background as a healthcare investor. She previously served as director of healthcare investment at Touchstone Innovations (formerly Imperial Innovations) in London and earlier worked in R&D at biotech companies including Celltech and Oxford GlycoSciences. She holds a BSc from the University of Texas at Austin and an MBA from Imperial Business School.
Contact· published on Maina's own website
Invests in
BiotechMedical Devices
Board director at Mediar Therapeutics
Intro paths
In turn, Maina can intro founders to Mediar Therapeutics's investors below.
Mediar Therapeutics's investors · 9
Experience
- Sofinnova PartnersPartnercurrent2018 — presentParis Area, France
- PsiOxus TherapeuticsInvestor Director2010 — 2017
- CellmedicaNon-Exec Director2007 — 2017
- Touchstone InnovationsDirector- Healthcare Investments2006 — 20177 Air Street, london
- Molecular VisionNon-Exec Director2007 — 2012
- Independent consultant2005 — 2006
- Celltech R&DScientist2004 — 2005
- Oxford GlycoSciencesScientist2002 — 2004
- Chimeric Therapies IncScientist1997 — 2002
- GeneMedicineScientist1994 — 1997
Skills & more
From Maina's professional profile.
Deals · 1
Mediar TherapeuticsBoard seat
via Sofinnova Partners · filed Dec 2025 · $75.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Enyo PharmaMironid LtdMyricx BioNuagePurespring TherapeticsSitryx Therapeutics
Sources: SEC Form D filings · the firm's website.
Colleagues at Sofinnova Partners
Frequently asked questions
- Who is Maina Bhaman?
- Maina Bhaman is a Partner in Sofinnova's Capital Strategy, who joined in 2018 with a background as a healthcare investor. She previously served as director of healthcare investment at Touchstone Innovations (formerly Imperial Innovations) in London and earlier worked in R&D at biotech companies including Celltech and Oxford GlycoSciences. She holds a BSc from the University of Texas at Austin and an MBA from Imperial Business School.
- Where does Maina Bhaman work?
- Maina Bhaman is Partner at Sofinnova Partners and Board director at Mediar Therapeutics.
- What does Maina Bhaman invest in?
- Maina Bhaman invests in Biotech, Medical Devices.
- What check size does Maina Bhaman write?
- Maina Bhaman typically writes checks of $100K – $5M.
- What boards does Maina Bhaman sit on?
- Maina Bhaman holds tracked board seats at Mediar Therapeutics.
- What companies has Maina Bhaman invested in?
- Investments tracked here include Enyo Pharma, Mediar Therapeutics, Mironid Ltd, Myricx Bio, Nuage, Purespring Therapetics, Sitryx Therapeutics.
- Where did Maina Bhaman go to school?
- Maina Bhaman studied at Imperial College London (MBA); The University of Texas at Austin (BSc, Biochemistry).
Same school
Also attended Imperial College London591
+ 585 more
Also attended The University of Texas at Austin506
+ 500 more